Author

D. R. Rivas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

B. G. Patty· 1 shared C. N. Smith· 1 shared D. Lee· 1 shared J. S. Blackburn· 1 shared M. V. C. Dela Cerna· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. G. Patty

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A screen of FDA-approved drugs identifies inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3)

D. R. Rivas, M. V. C. Dela Cerna, C. N. Smith, B. G. Patty, D. Lee, J. S. Blackburn

The paper screens FDA-approved drugs to identify inhibitors of PTP4A3 (PRL-3), finding five specific inhibitors and two broad inhibitors that block PRL-3-induced migration without affecting cell viability.

bioRxiv · May 24, 2020Cancer Biology